Puhlmann Markus 4
4 · Perspective Therapeutics, Inc. · Filed Jun 24, 2024
Insider Transaction Report
Form 4
Puhlmann Markus
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2024-06-20+150,000→ 150,000 totalExercise: $10.65Exp: 2034-06-20→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the monthly anniversary after the Grant Date (06/20/2024), subject to a continued service relationship.